Atlas Trials

Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis

Clinical trial NCT03068234 · UNKNOWN

Trial details

NCT number
NCT03068234
Sponsor
RenJi Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Systemic Sclerosis
Start date
2017-05-01
Primary completion
2019-04-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.